Standout Papers

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcome... 2019 2026 2021 2023 532
  1. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial (2019)
    Anders Widmark, Adalsteinn Gunnlaugsson et al. The Lancet

Immediate Impact

55 standout
Sub-graph 1 of 19

Citing Papers

Radiotherapy toxicities: mechanisms, management, and future directions
2025 Standout
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
32 intermediate papers

Works of Lars Franzén being referenced

Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA)
2008
Boron Neutron Capture Therapy for Glioblastoma Multiforme: Clinical Studies in Sweden
2003
and 9 more

Author Peers

Author Last Decade Papers Cites
Lars Franzén 1458 1702 568 858 87 3.2k
Frank Zimmermann 954 1737 894 746 99 3.1k
Joachim Widder 892 1518 468 953 114 2.8k
Madeleine Kane 667 1554 741 962 59 3.9k
Peter van Luijk 1228 1420 500 1044 72 2.8k
Emile F.I. Comans 2794 2041 1102 414 99 5.7k
Guido Hildebrandt 1962 1180 770 906 179 4.5k
Patrick Flamen 2589 2358 1627 409 179 5.5k
Glenn E. Sheline 989 1896 1165 321 91 5.6k
Michael McLean 422 1752 1183 867 100 3.4k
Hans C. Steinert 2854 2378 969 451 98 5.8k

All Works

Loading papers...

Rankless by CCL
2026